Home   Resources   QC Articles   Designing a Quality Control Strategy

Designing a Quality Control Strategy

In the modern laboratory three questions must be answered.

By Curtis A. Parvin, PhD, John Yundt-Pacheco and Max Williams

Quality Assurance Series

Editor's note: This is the third in a multi-part quality assurance series.

Many of the ideas about how to design good quality control (QC) strategies to meet the needs of a laboratory were formulated in an era when most lab testing was performed in batches. In this setting, both patient specimens and QC samples were included in each batch of testing. The QC sample results were used to decide whether the patient results in the batch were acceptable. If the QC results were deemed acceptable, it was concluded that the patient results in the batch were also acceptable. If the QC results were unacceptable, it was assumed there was a problem with the batch that was adversely affecting the QC samples and patient specimens.

Fig. 1: A Batch Testing Process

In the batch testing setting there is a natural association between the set of QC samples and the set of patient specimens that make up the batch (Fig. 1). With batch testing there are two questions that must be answered to define a QC strategy-how many QC samples to include in the batch and what QC rule(s) to apply to the QC sample results to decide whether the batch is acceptable.

Traditional approaches to designing QC strategies focus on finding answers to these two questions that will provide the statistical power needed to detect a "critical" out-of-control error condition in a batch. For instance, Westgard proposes tools such as power function graphs and Op-Spec charts to help find a QC strategy that has a high probability of giving a QC rule rejection when a "critical" out-of-control error condition exists.1

Today's QC Strategy

In the modern laboratory, the majority of instruments perform discrete testing. With automated discrete analyzers there is no longer a natural association between a set of QC results and a batch of patient specimens. Instead, QC results simply reflect the status of the test system at a point in time when the QC samples are tested. If the QC sample results are unacceptable, it suggests that a problem has occurred sometime earlier. This implies that if the laboratory doesn't do something to correct the problem then most assuredly future patient results will be adversely affected, but it doesn't give the laboratory any information about how many previous patient results were adversely affected (Fig. 2).

Fig. 2: An Automated Discrete Testing Process
Fig. 2: An Automated Discrete Testing Process

Thus, there are three questions that must be answered to define a QC strategy in the modern laboratory:

  1. How many QC samples should be tested at a point in time?
  2. What QC rules should be applied to the QC sample results?
  3. When should QC testing occur?

Finding good answers to the "when" question is one of the hot topics in modern QC strategy design and there are myriad opinions concerning what is minimal and ideal.

Determining 'When'

In our last article in this series, we argued that the primary focus of laboratory QC should be the patient.2 In this vein, decisions about when to test QC samples should be made based on the impact those choices will have on the risk of producing unreliable patient results.

In April, Bio-Rad hosted a Convocation of Experts on Laboratory Quality in Salzburg, Austria. The participants were divided into five working groups that addressed different issues in laboratory quality. One of the workgroups considered the issue of when QC testing should be performed. They concluded that QC testing should be performed any time an event occurs that has the potential to adversely affect the testing process (e.g., when reagent lots change, when test system maintenance occurs or when calibrations are performed). If these events are planned and scheduled, QC should be performed prior to the event and again after the event.

Testing QC samples just prior to the event provides the laboratory a level of assurance that the patient results produced since the last QC testing up to the time of the event are acceptable. Testing QC samples immediately after the event gives the laboratory a level of assurance that the test system is in control prior to resuming the testing of patient specimens. In the case of an unplanned event (such as a system failure), there is no opportunity to do QC testing just prior to the unplanned event. In these cases QC testing should still be done immediately after the event to assure that the testing process is operating correctly before continuing with patient testing.

Determining Frequency

How does the lab decide how frequently QC evaluations should be routinely performed? During these intervals, if a test system malfunctions it is not associated with any notable event. Therefore, the laboratory needs to schedule QC evaluations in such a way as to minimize the risk of too many patient results being produced and reported before the laboratory becomes aware of the system malfunction. All too often, lab managers only look only at what the regulations dictate and their staff competencies when scheduling QC evaluations.

For the high-performing laboratory, a place to start is to consider really big out-of-control error conditions. When there is a failure causing a major error, all the patient specimens tested while the failure is present will be unreliable and the error will be detected (because it is so large) at the next scheduled QC evaluation.

In Fig. 3, each vertical line represents a patient specimen being tested. Asterisks denote unreliable patient results produced during the existence of the out-of-control error condition, each diamond represents a routinely scheduled QC evaluation, and a red diamond means the QC results are rejected. In the worst case, the failure occurs right after the last successful QC evaluation-then all the patient specimens between the last successful QC evaluation and the QC evaluation that detects the problem are unreliable. The best case scenario is when the failure occurs just before the QC evaluation that detects the problem; no patient results are compromised. If we consider that a test system failure can begin at any specimen with equal probability, then the expectation is that half the number of patient specimens tested between QC evaluations will be affected in the event of an undetected test system failure. In this case, the number of unreliable patient results produced has little to do with the number of QC samples tested or the QC rule used, but is directly related to the number of patient specimens tested between routinely scheduled QC evaluations.

Fig. 3: Illustration of a Large Out-of-Control Error in an Automated Discrete Testing Process
Fig. 3: Illustration of a Large Out-of-Control Error in an Automated Discrete Testing Process

What happens if results are held until the next QC evaluation? Instead of all the results being compromised, the error would have been detected, corrected and the patient specimens reprocessed before they were reported. Holding patient results until the test method has been checked with a subsequent QC evaluation is one of the best ways to prevent a test system failure that occurs after the last successful QC evaluation. Unfortunately, holding results may not be logistically possible. If results must be released as soon as they are produced, careful thought should be given to the number of unreliable reported patient results that can be tolerated in the event of a test system failure. The number of patient specimens tested between QC evaluations should be selected so that the expected number of unreliable patient results produced during an undetected test system failure is no larger than the tolerable threshold. We have published one possible approach to systematically determining limits on the number of patient specimens that can be tested between QC evaluations to control the expected number of unreliable patient results reported during the existence of an undetected test system failure.3

Dr. Parvin is manager of Advanced Statistical Research; John Yundt-Pacheco is Scientific Fellow; and Max Williams is Global Scientific and Professional Affairs Manager, Bio-Rad.

References

  1. Westgard JO. Assuring the right quality right. Madison WI: Westgard QC Inc., 2007.
  2. Parvin CA, Yundt-Pacheco J, Williams M. The focus of laboratory quality control: Why QC strategies should be designed around the patient, not the instrument.ADVANCE for Administrators of the Laboratory 2011;20(3):48-9.
  3. Parvin CA. Assessing the impact of the frequency of quality control testing on the quality of reported patient results. Clin Chem 2008;54:2049-54.

Copyright 2015 Merion Matters. All rights reserved.

Your Privacy Matters

Before you visit, we want to let you know we use cookies to offer you a better browsing experience. To learn more about how we use cookies, please review our Cookie Policy, accessible from the Manage Preferences link below. We would appreciate your confirmation by either accepting all cookies or by declining and managing your cookie preferences under the Manage Preferences link below.

Back

Cookie Preferences

We use various types of cookies to enhance and personalize your browsing experience on our website. You may review the various types in the descriptions below and decide which cookie preferences you wish to enable. If you wish to decline all non-essential cookies, you may browse our site using strictly-necessary cookies. To learn more about how we use cookies, please visit our Cookie Policy.

Strictly-Necessary Cookies

These cookies are essential for our website to function properly. They either serve as the sole purpose of carrying out network transmissions or they allow you to browse and use features, such as accessing secure areas of the site. These cookies are strictly necessary because services like the shopping cart and invoicing cannot be provided without these cookies. Since these cookies are strictly necessary in order for our website to function, no consent is required to enable them. If you wish to disable these cookies, please update your settings under your browser’s preferences. If these cookies are disabled, please be aware that you will not be able to access certain features of the site like purchasing online.

Functionality Cookies

These cookies improve your browsing experience and provide useful, personalized features. They are used to remember selections that you have made such as your preferred language, region, and username. They also remember changes that you made in text sizes, fonts, and other customizable parts of the Web. Together, this information allows us to personalize features on our website in order to provide you with the best possible browsing experience. The information that these cookies collect is anonymous and cannot track your activity on other websites.

Analytics Cookies

These cookies are used to help ensure that your browsing experience is optimal. They collect anonymous data on how you use our website in order to build better, more useful pages. For instance, we can recognize and count the number of visitors, see how visitors moved around the site, and we can identify which pages returned error messages. This information enables us to enhance your experience and helps us troubleshoot any issues that prevented you from reaching the content that you needed. In order to improve the performance of our site, we use products such as WebTrends OnDemand and Google Analytics to track site usage. You can find the list of products that we use to collect information that is relevant to Analytics Cookies here:

  • Google Analytics
  • Adobe Analytics
  • SessionCam
  • ForeSee
  • WebTrends On Demand

Targeting or Advertising Cookies

These cookies are used to deliver personalized content based on your interests through third-party ad services. This allows us to improve your online experience by helping you find products that are relevant to your interests faster. They remember websites that you have visited and the information is shared with other organizations such as advertisers. These cookies are also used to limit the number of times you see an ad and help measure the effectiveness of a marketing campaign. You can find the list of products that we use to collect information that is relevant to Advertising Cookies here:

  • Marketo
  • Kenshoo
  • Doubleclick

Log In / Register

Log In / Register